Viewing Study NCT04728893


Ignite Creation Date: 2025-12-25 @ 1:11 AM
Ignite Modification Date: 2025-12-27 @ 1:46 AM
Study NCT ID: NCT04728893
Status: RECRUITING
Last Update Posted: 2025-12-24
First Post: 2021-01-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module